• Common shares of Psyched Wellness (PSYC) are now eligible for electronic clearing and settlement through the DTC
  • Shares will continue to trade under the ticker symbol PSYCF on the OTCQB
  • DTC eligibility allows Psyched shares to be accessible to an even broader range of investors
  • Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products
  • Psyched Wellness (PSYC) is up 4 per cent, trading at C$0.26 per share at 12 pm ET

Common shares of Psyched Wellness (PSYC) are now eligible for electronic clearing and settlement through the DTC.

The Depository Trust Company (DTC) manages the electronic clearing and settlement of publicly traded companies in the United States.

Psyched common shares are now fully DTC eligible and will continue to trade under the ticker symbol PSYCF on the OTCQB.

Through an electronic method of clearing securities, DTC eligibility simplifies the process of trading and transferring the company’s common shares between brokerages in the United States.

Jeff Stevens, CEO, comments,

“By achieving DTC eligibility, Psyched shares become more accessible to an even broader range of investors. This important milestone will strengthen our U.S. and global shareholder base and increase the liquidity of our common shares to the benefit of all investors. Psyched stock is now traded in Canada (PSYC), Germany (5U9) and the United States (PSYCF) positioning the Company in both domestic and international markets to continue to grow a global investor base.”

Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods.

Psyched Wellness (PSYC) is up 4 per cent, trading at C$0.26 per share at 12 pm ET.

More From The Market Online

CCrest Labs receives Red Light Holland’s largest psilocybin order

Red Light Holland's (CSE:TRIP) largest shipment to date of 5 kilograms of psilocybin truffles has been received by CCrest Labs in Montreal.

Red Light Holland reports record psilocybin shipment

Psychedelics stock Red Light Holland (CSE:TRIP) exports 5 kilograms of natural psilocybin truffles to CCrest Laboratories in Montreal.

Psychedelic stock begins take-home LSD microdosing clinical trial

MindBio Therapeutics (CSE:MBIO) secures approvals for MB22001 – a form of LSD – microdosing use by patients in a controlled clinical trial.

Red Light Holland begins experimental research on psilocybin truffles

Red Light Holland has revealed that it has officially begun an experimental research project on its psilocybin truffles.